Nab-paclitaxel-based regimens with docetaxel-based regimens as neoadjuvant treatment for early breast cancer

Conclusions This study presented antitumor activity of nPBC and DBC in patients with early breast cancer receiving neoadjuvant treatment in a real-world setting. Further prospective research is warranted to confirm the results and to develop biomarkers for better patient selection.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research